|
[1]
|
Hay ID,Bayer MF,Kaplan MM,et al. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays The Committee on Nomenclature of the American Thyroid[J]. Clin Chem,1991,37(11):2002-2008. |
|
[2]
|
Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease:nonthyroidal illness[J]. Clin Chem,1996,42(1):188-192. |
|
[3]
|
Owen PJ,Lazarus JH. Subclinical hypothyroidism:the case for treatment[J]. Trends Endocrinol Metab,2003,14(16):257-261. |
|
[4]
|
Tunbridge WM,Vanderpump MP. Population screening for autoimmune thyroid disease[J].Endocrinol Metab Clin North Am,2000,29(2):239-253. |
|
[5]
|
乔洁,陈名道.亚临床甲状腺疾病的诊断、治疗及病例分析[J]. 中华内分泌代谢杂志,2004,20(2):附录U001-U002.
|
|
[6]
|
Surks MI,Ortiz E,Daniels GH,et al. Subclinical thyroid disease:scientific review and guidelines for diagnosis and management[J]. JAMA,2004,291(2):228-238. |
|
[7]
|
滕卫平.开展亚临床甲状腺功能减退症的临床研究[J].中华内分泌代谢杂志,2004,20(2):93-95.
|
|
[8]
|
Fatourechi V,Laukorani M,Schryver PG,et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L)[J]. Mayo Clin Proc,2003,78(5):554-560. |
|
[9]
|
Jorde R,Waterloo K,Storhaug H,et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment[J].J Clin Endocrinol Metab,2006,91(1):145-153. |
|
[10]
|
Altinova AE,Törüner FB,Aktuük M,et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism[J]. Clin Endocrinol(Oxf),2006,65(4):530-535. |
|
[11]
|
阳俊琴.第一届全国老年人内分泌代谢系统疾病学术会议纪要[J].中华老年医学杂志,2003,22(7):440.
|
|
[12]
|
Barbé F,Klein M,Chango A,et al. Homocysteine,folate,vitamin B12,and transcobalamins in pationts undergoing successive hypo-and hyperthyroid states[J].J Clin Endocrinol Metab,2001,86(4):1845-1846. |
|
[13]
|
Devaraj S,Xu DY,Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis[J]. Circulation,2003,107(3):398-404. |
|
[14]
|
Cantürk Z,Cetinarslan B,Tarkun I,et al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism[J]. Thyroid,2003,13(10):971-977. |
|
[15]
|
Kahaly GJ.Cardiovascular and atherogenic aspects of subclinical hypothyroidism[J]. Thyroid,2000,10(8):665-679. |
|
[16]
|
Rodondi N,Newman AB,Vittinghoff E,et al. Subclinical hypothyroidism and the risk of heart failure,other cardiovascular events,and death[J],Arch intern Med,2005,165(21):2460-2466. |
|
[17]
|
Díez JJ,Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years:an analysis of natural course and factors for the development of overt thyroid failure[J]. J Clin Endocrinol Metab,2004,89(10):4890-4897. |
|
[18]
|
李新禾.亚临床甲亢108例临床分析[J].实用糖尿病杂志,2007,15(5):36-37.
|
|
[19]
|
Biondi B,Palmieri EA,Klain M,et al. Subclinical hyperthyroidism:clinical features and treatment options[J]. Eur J Endocrinol,2005,152(1):1-9. |
|
[20]
|
Cappola AR,Fried LP,Arnold AM. Thyroid status,cardiovascular risk,and mortality in older adults[J]. JAMA,2006,295(9):1033-1041. |
|
[21]
|
Cavallo-Perin P,Bruno A,Boine L,et al. Insulin resistance in Graves' disease:a quantitative in-vivo evaluation[J]. Eur J Clin Invest,1988,18(16):607-613. |
点击查看大图
下载: